Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy
about
The discovery and development of selective estrogen receptor modulators (SERMs) for clinical practiceEffects of ospemifene on the female reproductive and urinary tracts: translation from preclinical models into clinical evidenceBreast-related effects of selective estrogen receptor modulators and tissue-selective estrogen complexesEstrogen receptors: therapies targeted to receptor subtypes.Progress and prospects in treating postmenopausal vaginal atrophy.
P2860
Lasofoxifene, a new selective estrogen receptor modulator for the treatment of osteoporosis and vaginal atrophy
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@ast
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@en
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@nl
type
label
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@ast
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@en
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@nl
prefLabel
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@ast
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@en
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@nl
P2860
P1476
Lasofoxifene, a new selective ...... teoporosis and vaginal atrophy
@en
P2093
Luigi Gennari
P2860
P304
P356
10.1517/14656560903127241
P407
P577
2009-09-01T00:00:00Z